Neurotoxic effects of medications: An update;Neuropathies médicamenteuses: Mise à jour récente des dionnées (1996 à 2003)

Revue Medicale de Liege

Volumn 59, Issue SUPPL. 1, 2004, Pages 118-123

  Arne Bes M C ^a  

^a CHU RANGUEIL   (France)

Author keywords

Antineoplastic agents; Antiretroviral medications; Metronidazole; Peripheral neuropathy; Thalidomide

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; CARBOPLATINE; CISPLATINE; COLCHICINE; DAPSONE; DISULFIRAM; DOCETAXEL; METRONIDAZOLE; NITROFURANTOIN; OXALIPLATIN; OXALIPLATINE; PACLITAXEL; PACLITAXEL DERIVATIVE; PLATINUM DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STATIN; SURAMIN; TACROLIMUS; THALIDOMIDE; UNCLASSIFIED DRUG; VINCA ALKALOID; VINCRISTINE SULFATE;

ALCOHOLISM; AUTONOMIC NEUROPATHY; AXONAL POLYNEUROPATHY; CLINICAL FEATURE; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG WITHDRAWAL; GENETIC DISORDER; HUMAN; NEUROTOXICITY; PATIENT MONITORING; PERIPHERAL NEUROPATHY; QUALITY OF LIFE; SENSORIMOTOR NEUROPATHY; SIDE EFFECT; VULNERABLE POPULATION;

ANTI-RETROVIRAL AGENTS; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CISPLATIN; COLCHICINE; HUMANS; INTERFERON-ALPHA; NEUROTOXICITY SYNDROMES; ORGANOPLATINUM COMPOUNDS; PACLITAXEL; PERIPHERAL NERVOUS SYSTEM DISEASES; TAXOIDS; THALIDOMIDE;

EID: 2542479994     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Bakshi N, Maselli RA, Gospe SM Jr, et al. - Fulminant demyelinating neuropathy mimicking cerebral death. Muscle nerve, 1997, 20, 1595-1597.
2. Burns BV, Schotton JC. - Vocal fold palsy following vinca alkaloid treatment. J. Laryngol Otol, 1998, 112 (5), 485-487.
3. Graf WD, Chance PF, Lensch MW, et al. - Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A. Cancer, 1996, 77, 1356-1362.
4. Hildebrandt G, Holler E, Woenkhaus M, et al. - Acute deterioration of Charcot-Marie-Tooth disease 1A (CMT 1A) following 2 mg of vincristine chemotherapy. Ann Oncol, 2000, 11, 743-747.
5. Chaudhry V, Rowinsky EK, Sartorius SE, et al. - Peripheral neuropathy from taxol and cisplatin combinaison chemotherapy: clinical and electrophysiological studies. Ann Neurol, 1994, 35, 304-311.
6. Peltier AC, Russell JW. - Recent advances in drug-induced neuropathies. Curr Opin Neurol, 2002, 15, 633-638.
7. Apfel SC. - Neurotrophic factors in the treatment of neurotoxicity: an overview. Neurotoxicology, 1996, 17, 839-844.
8. New PZ, Jackson CE, Rinaldi D, et al. - Peripheral neuropathy secondary to docetaxel (Taxotere). Neurology, 1996, 46, 108-111.
9. Vahdat L, Papadopoulos K, Lange D, et al. - Reduction of paclitaxel-induced peripheral neuropathy with glutamine. Clin Cancer Res, 2001, 7, 1192-1197.
10. Kilpatrick TJ, Phan S, Reardon K, et al. - Leukaemia inhibitory factor abrogates Paclitaxel-induced axonal atrophy in the Wistar rat. Brain Res, 2001, 911, 163-167.
11. Chaudhry V, Eisenberger MA, Sinibaldi VJ, et al. - A prospective study of suramin-induced peripheral neuropathy. Brain, 1996, 119, 2039-2052.
12. Soliven B, Dhand UK, Kobayashi K, et al. - Evaluation of neuropathy in patients on suramin treatment. Muscle Nerve, 1997, 20, 83-91.
13. Carr A, Cooper DA. - Adverse effects of antiretroviral therapy. Lancet, 2000, 356, 1423-1430.
14. Moyle G. - Toxicity of antiretroviral nucleoside and nucleotide analogues. Drug Saf, 2000, 23, 467-481.
15. Dalakas MC, Semino-Mora C, Leon-Monzon M. - Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC). Lab Invest, 2001, 81, 1537-1544.
16. Ayres RC, Dousset B, Wixon S, et al. - Peripheral neurotoxicity with tacrolimus. Lancet, 1994, 343, 862-863.
17. Wilson JR, Conwit RA, Eidelman BH, et al. - Sensorimotor neuropathy resembling CIDP in patients receiving FK506. Muscle Nerve, 1994, 17, 528-532.
18. Jeppesen U, Gaist D, Smith T, et al. - Statins and peripheral neuropathy. Euro J Clin Pharmacol, 1999, 54, 835-838.
19. Irioka T, Yamada M, Yamawaki M, et al. - Acute autonomic and sensory neuropathy after interferon alpha-2b therapy for chronic hepatitis C. J Neurol Neurosurg Psychiatry, 2001, 70, 408-410.
20. Tellez-Zenteno JF, Negrete-Pulido O, Nunez M, et al. - Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature. Rev Neurol, 2002, 35 (7), 644-646.
21. Quattrini A, Comi G, Nemni R, et al. - Axonal neuropathy associated with interferon- alpha treatment for hepatitis C: HLA-DR immunoreactivity in Schwann cells. Acta Neuropathol, 1997, 94, 504-508.
22. Dano P, Tamman D, Brosset C, et al. - Peripheral neuropathies caused by disulfiram. Rev Neurol (Paris), 1996, 152 (4), 294-295.
23. Kapoor K, Chandra M, Nag D, et al. - Evaluation of metronidazole toxicity: a prospective study. Int J Clin Pharmacol Res, 1999, 19 (3), 83-88.
24. Mery L, Dega H, Prost C, et al. - Dapsone-induced sensory peripheral neuropathy. Ann Dermatol Venereol, 2003, 130 (4), 447-449.
25. Benedetti-Bardet C, Guy C, Boudignat O, et al. - Effets indésirables de la Disulone: résultats de l'enquête française de pharmacovigilance. Thérapie, 2001, 56, 295-299.
26. Spring PJ, Sharpe DM, Hayes MW. - Nitrofurantoin and peripheral neuropathy: a forgotten problem? Med J Aust, 2001, 174, 153-154.
27. Calabrese L, Fleischer AB. - Thalidomide: current and potential clinical applications. Am J Med, 2000, 108, 487-495.
28. Chaudhry V, Chaudhry M, Crawford TO, et al. - Toxic neuropathy in patients with pre-existing neuropathy. Neurology, 2003, 60, 337-340.
29. Quasthoff S, Hartung HP. - Chemotherapy-induced peripheral neuropathy. J Neurol, 2002, 249, 9-17.
30. Cornblath DR, Chaudhry V, Carter K, et al. - Total Neuropathy score: validation and reliability study. Neurology, 1999, 53, 1660-1664.